Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The statins: new properties]].

Pierre Ambrosi1, Patrick Villani, Gilbert Habib

  • 1Laboratoire de Thérapeutique, Faculté de Médecine, bd Jean Moulin, Service de Cardiologie B, Hôpital de La Timone, Marseille, France. pierre.ambrosi@ap-hm.fr

Therapie
|June 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotype, genotype and prognosis of Apical Hypertrophic Cardiomyopathies: A French multicentric cohort.

European heart journal. Cardiovascular Imaging·2026
Same author

[Marketing authorisation of new drugs: a worrying observation].

La Revue du praticien·2026
Same author

Sudden cardiac death and major arrhythmic events in patients with Fabry disease: Risk stratification in the French Heart Fabry cohort multicenter study.

Heart rhythm·2026
Same author

Early aortic valve intervention in asymptomatic severe aortic stenosis: a clinical dilemma in evolution.

European heart journal open·2026
Same author

Intense Myocardial Uptake in a Patient with Fabry Disease - a new cause of false positive of Bone Scintigraphy mimicking cardiac amyloidosis.

European heart journal. Cardiovascular Imaging·2026
Same author

Laminopathies: natural history and risk prediction of heart failure.

European heart journal·2026
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Statins primarily reduce coronary heart disease events by lowering low-density lipoprotein (LDL) cholesterol. This action stabilizes plaques, reduces inflammation, and improves endothelial function, contributing to cardiovascular event prevention.

Area of Science:

  • Cardiovascular Pharmacology
  • Lipid Metabolism
  • Endothelial Function

Context:

  • Statin therapy is widely used for cardiovascular disease prevention.
  • Previous studies compared statins with other lipid-lowering agents like cholestyramine and ileal bypass.
  • The primary mechanism of statin benefit is attributed to low-density lipoprotein (LDL) cholesterol reduction.

Purpose:

  • To elucidate the multifaceted mechanisms by which statins exert their cardioprotective effects.
  • To investigate the physiological consequences of LDL-cholesterol lowering by statins.
  • To explore potential pleiotropic effects of statins beyond lipid modification.

Summary:

  • Statin-induced LDL-cholesterol reduction leads to plaque stabilization, decreased inflammation, and improved endothelial function, evidenced by enhanced vasorelaxation.

Related Experiment Videos

  • Statins lower C-reactive protein, but effects on other acute-phase proteins are inconsistent.
  • While direct antithrombotic effects are debated, statins inhibit L-mevalonic acid synthesis, impacting GTP-binding proteins like Rho and Ras.

    • Impact:

    • Statin therapy significantly reduces coronary heart disease events through LDL-cholesterol lowering.
    • Pleiotropic effects, such as anti-inflammatory and endothelial function improvements, contribute to cardiovascular protection.
    • Further research is needed to confirm the clinical significance of statin-induced isoprenylation inhibition at therapeutic concentrations.